Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Kolb

Showing results (41-50 of 278) with videos related to

Pageof 28
Sort By:
The Lancet. Respiratory Medicine|February 8, 2018
Idiopathic pulmonary fibrosis: idiopathic no more?Victor J Thannickal, Athol Wells, Martin Kolb
Respiratory Research|January 25, 2002
A new direction in the pathogenesis of idiopathic pulmonary fibrosis?Jack Gauldie, Martin Kolb, Patricia J Sime
The European Respiratory Journal|January 29, 2021
The evolution of the <i>European Respiratory Journal</i>: weathering the publishing pandemicMartin Kolb, James D Chalmers, Marc Humbert
European Respiratory Review : an Official Journal of the European Respiratory Society|February 22, 2023
Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosisMartin Kolb, Bruno Crestani, Toby M Maher
Arthritis & Rheumatology (Hoboken, N.J.)|January 11, 2016
Editorial: Extracellular Matrix: The Common Thread of Disease Progression in Fibrosis?Martin Kolb, Jack Gauldie, Pierre-Simon Bellaye
The European Respiratory Journal|April 1, 2023
Design considerations and implications of findings on progressive pulmonary fibrosis from the prospective Canadian Registry for Pulmonary FibrosisChristopher J Ryerson, Nathan Hambly, Martin Kolb
American Journal of Respiratory and Critical Care Medicine|February 13, 2016
Mucking around in the Genome: MUC5B in Idiopathic Pulmonary FibrosisMartin Kolb, Eric S White, Jack Gauldie
The European Respiratory Journal|March 26, 2021
Guideline-directed management of COVID-19: Do's and Don'tsMartin Kolb, Anh Tuan Dinh-Xuan, Laurent Brochard
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|July 29, 2005
Transforming growth factor-beta: importance in long-term peritoneal membrane changesPeter J Margetts, Kook-Hwan Oh, Martin Kolb
Expert Opinion on Emerging Drugs|April 8, 2024
Treatment of idiopathic pulmonary fibrosis: an update on emerging drugs in phase II & III clinical trialsSarah MacIsaac, Dujrath Somboonviboon, Ciaran Scallan, et al.
Pageof 28

Showing results (41-50 of 278) with videos related to

Sort By:
Pageof 28
The Lancet. Respiratory Medicine|February 8, 2018
Idiopathic pulmonary fibrosis: idiopathic no more?Victor J Thannickal, Athol Wells, Martin Kolb
Respiratory Research|January 25, 2002
A new direction in the pathogenesis of idiopathic pulmonary fibrosis?Jack Gauldie, Martin Kolb, Patricia J Sime
The European Respiratory Journal|January 29, 2021
The evolution of the <i>European Respiratory Journal</i>: weathering the publishing pandemicMartin Kolb, James D Chalmers, Marc Humbert
European Respiratory Review : an Official Journal of the European Respiratory Society|February 22, 2023
Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosisMartin Kolb, Bruno Crestani, Toby M Maher
Arthritis & Rheumatology (Hoboken, N.J.)|January 11, 2016
Editorial: Extracellular Matrix: The Common Thread of Disease Progression in Fibrosis?Martin Kolb, Jack Gauldie, Pierre-Simon Bellaye
The European Respiratory Journal|April 1, 2023
Design considerations and implications of findings on progressive pulmonary fibrosis from the prospective Canadian Registry for Pulmonary FibrosisChristopher J Ryerson, Nathan Hambly, Martin Kolb
American Journal of Respiratory and Critical Care Medicine|February 13, 2016
Mucking around in the Genome: MUC5B in Idiopathic Pulmonary FibrosisMartin Kolb, Eric S White, Jack Gauldie
The European Respiratory Journal|March 26, 2021
Guideline-directed management of COVID-19: Do's and Don'tsMartin Kolb, Anh Tuan Dinh-Xuan, Laurent Brochard
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|July 29, 2005
Transforming growth factor-beta: importance in long-term peritoneal membrane changesPeter J Margetts, Kook-Hwan Oh, Martin Kolb
Expert Opinion on Emerging Drugs|April 8, 2024
Treatment of idiopathic pulmonary fibrosis: an update on emerging drugs in phase II & III clinical trialsSarah MacIsaac, Dujrath Somboonviboon, Ciaran Scallan, et al.
Pageof 28